Astellas Pharma Inc.
$9.98
24H
Market Cap
Volume
Supply
Price Chart
About Astellas Pharma Inc. - 4503.T
Astellas Pharma is a Japanese multinational pharmaceutical company that develops and markets pharmaceuticals in a wide range of therapeutic areas, including urology, immunology, and cardiology. The company was formed from the merger of Yamanouchi Pharmaceutical Co., Ltd. and Fujisawa Pharmaceutical Co., Ltd. in 2005.
What are Astellas Pharma Inc.'s core values and mission statement?
Astellas Pharma's core values include being patient-focused, results-driven, and committed to advancing global healthcare through collaborative innovation. Its mission is to contribute to improving the health of people around the world through the provision of innovative and reliable pharmaceutical products.
Who founded Astellas Pharma Inc. and when?
Astellas Pharma was founded through the merger of two Japanese pharmaceutical companies, Yamanouchi Pharmaceutical Co., Ltd. and Fujisawa Pharmaceutical Co., Ltd., in April 2005.
Who leads Astellas Pharma Inc.?
Astellas Pharma is typically led by a President and CEO; however, the specific individual holding this position can change over time. To obtain the most current information, it's recommended to consult the latest corporate communications or official company website.
Where is Astellas Pharma Inc. located, and what is its base country?
Astellas Pharma Inc. is headquartered in Tokyo, Japan. Japan is the base country for this multinational pharmaceutical company.
On which exchanges is Astellas Pharma Inc. traded?
Astellas Pharma is traded on the Tokyo Stock Exchange and the Nagoya Stock Exchange in Japan.
Historical data
Astellas Pharma Inc. (4503) Price Live Data
The live price of Astellas Pharma Inc. (4503) is $9.98, with a trading volume of 10,890,700 in the last 24 hours. Wrapstocks updates the 4503 price in real-time. Astellas Pharma Inc. is up 3.16% in the last 24 hours. The company has a live market cap of $17,898,097,252.76 and a supply of 1,793,100,064 4503 stocks.
Astellas Pharma Inc. (4503) is traded on Tokyo Stock Exchange, and currently, the market is closed; trading will be resumed in 4 hours and 55 minutes.
